Consistent with our data, it has been shown that the stimulation of LXR could down-regulate β-catenin targets such as Bmp4, Myc, Cyclin D1, and Mmp7 participating in the survival and proliferation of colon cancer cells [19]. The gene discussed is BMP4; the disease is malignant colon neoplasm.